Hadrup BioMed Holding ApS

CVR 38034871 · Private limited company (ApS) · Active · Low risk

Hadrup BioMed Holding ApS is a Private limited company (ApS), founded on , based in Virum. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 9 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 2.6m and a net result of DKK 7,013. CEO: Sine Hadrup.

Bankruptcy risk for Hadrup BioMed Holding ApS

0.1%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 27% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO's previous bankruptcies1 · bankruptcy rate 14.2%1.6×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Negative equityNo · bankruptcy rate 5.1%0.58×
Loss for the yearNo · bankruptcy rate 5.3%0.60×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38034871
Status
Active
Company type
Private limited company (ApS)
Founded
(10 years)
Address
Kirkebakken 12
2830 Virum
Municipality
Lyngby-Taarbæk
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 40k
Auditor
KPMG
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 9
Missing annual reportNo
Negative equityNo
Equity ratio98.7%
Current ratio7,851%
Moves (last 2 years)0
CEO changes in total3
CEO's previous bankruptcies1
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -28kDKK -57k
Net profitDKK 7,013DKK 190k
EquityDKK 2.6mDKK 2.6m
Total assetsDKK 2.6mDKK 2.6m
CashDKK 478k–
Short-term debtDKK 33k–
Tax owedDKK 7,480–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · KPMG.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025146
1 Jan 2024 – 31 Dec 2024140
1 Jan 2023 – 31 Dec 2023186 Late
1 Jan 2022 – 31 Dec 2022180
1 Jan 2021 – 31 Dec 2021182
1 Jan 2020 – 31 Dec 2020182
1 Jan 2019 – 31 Dec 2019148
1 Jan 2018 – 31 Dec 2018119
26 Sep 2016 – 31 Dec 2017151

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOSine HadrupCurrent
CEOLis Hanne Reker
Owner (100%)Sine HadrupCurrent
FounderSine HadrupCurrent

The CEOs' other companies

Sine Hadrup – 4 other companies, of which 2 bankrupt

Address history (0 moves)

Kirkebakken 12, 2830 Virum

Former names

Hadrup BioMed Holding ApS – now
Hadrup BioMed Holding IVS –

Other companies at the same address

Similar companies in Lyngby-Taarbæk

Questions and answers about Hadrup BioMed Holding ApS

Has Hadrup BioMed Holding ApS gone bankrupt?

No, Hadrup BioMed Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Hadrup BioMed Holding ApS?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of Hadrup BioMed Holding ApS?

Sine Hadrup is the CEO of Hadrup BioMed Holding ApS.

Who is the auditor of Hadrup BioMed Holding ApS?

Hadrup BioMed Holding ApS most recently used KPMG.

When was Hadrup BioMed Holding ApS founded?

Hadrup BioMed Holding ApS was founded on 26 September 2016.

What is the equity of Hadrup BioMed Holding ApS?

Equity was DKK 2.6m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.